Skip to main content

Adverum Biotechnologies, Inc.

ADVMDelisted Dec 9, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501756

Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Adverum Biotechnologies, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
92
−6 vs. Q4 2021
Shares held
63.2M
−2.70M (−4.1%) vs. Q4 2021
Total value
$82.4M
−$33.1M (−28.6%) vs. Q4 2021
New holders
10
13 more added
Sold out
16
42 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 92 institutions
Q1 2021: 132 institutionsQ2 2021: 118 institutionsQ3 2021: 110 institutionsQ4 2021: 98 institutionsQ1 2022: 92 institutionsQ2 2022: 77 institutionsQ3 2022: 78 institutionsQ4 2022: 59 institutionsQ1 2023: 55 institutionsQ2 2023: 58 institutionsQ3 2023: 61 institutionsQ4 2023: 61 institutionsQ1 2024: 61 institutionsQ2 2024: 68 institutionsQ3 2024: 77 institutionsQ4 2024: 70 institutionsQ1 2025: 71 institutionsQ2 2025: 59 institutionsQ3 2025: 50 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $82.4M
Q1 2021: $937.9MQ2 2021: $280.4MQ3 2021: $151.2MQ4 2021: $115.5MQ1 2022: $82.4MQ2 2022: $70.0MQ3 2022: $55.6MQ4 2022: $33.2MQ1 2023: $45.0MQ2 2023: $104.4MQ3 2023: $97.9MQ4 2023: $48.3MQ1 2024: $236.9MQ2 2024: $117.7MQ3 2024: $120.2MQ4 2024: $74.1MQ1 2025: $69.8MQ2 2025: $30.1MQ3 2025: $63.8MQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ADVM and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 202550$63.8M
Q2 202559$30.1M
Q1 202571$69.8M
Q4 202470$74.1M
Q3 202477$120.2M
Q2 202468$117.7M
Q1 202461$236.9M
Q4 202361$48.3M
Q3 202361$97.9M
Q2 202358$104.4M
Q1 202355$45.0M
Q4 202259$33.2M
Q3 202278$55.6M
Q2 202277$70.0M
Q1 202292$82.4M
Q4 202198$115.5M
Q3 2021110$151.2M
Q2 2021118$280.4M
Q1 2021132$937.9M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q4 2021.

Institutions holding ADVM in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Millennium Management LLC0$00.00%−23,125−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−22,311−100.0%Sold out
Squarepoint Ops LLC0$00.00%−15,064−100.0%Sold out
CSS LLC0$00.00%−14,000−100.0%Sold out
Credit Suisse AG0$00.00%−12,076−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−2,379−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−590−100.0%Sold out
Ellevest, Inc.0$00.00%−120−100.0%Sold out